✦ LIBER ✦

DB1 ESTIMATING THE LONG-TERM CLINICAL AND ECONOMIC BENEFITS OF INSULIN LISPRO IN TYPE 1 DIABETES IN THE UNITED KINGDOM: A COST-EFFECTIVENESS ANALYSIS BASED ON THE RESULTS OF A RECENT META-ANALYSIS

✍ Scribed by HT Smith; WJ Valentine; KS Boye; A Kalsekar; C Pratoomsoot

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An estimation of the long-term clinical

✍ C. Pratoomsoot; H. T. Smith; A. Kalsekar; K. S. Boye; J. Arellano; W. J. Valenti 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB

PDB55 Estimating the Cost-Effectiveness

✍ B. Curtis; R. Pollock; J. Smith-Palmer; W. Valentine 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PDB27 COST-EFFECTIVENESS OF EXENATIDE VE

✍ D Bruhn; S Malhan; S Kavuncubasi; J Smith-Palmer; V Reed 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Cost-effectiveness of detemir-based basa

✍ Palmer, Andrew J.; Roze, Stéphane; Valentine, William J.; Smith, Inger; Wittrup- 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 361 KB

PDB51 COST-EFFECTIVENESS OF EXENATIDE VE

✍ JL Palmer; CG Pinto; R Duarte; L Miguel; Z Gregor 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Effects of Losartan-based therapy on the

✍ Jiten Vora; George Carides; Paul Robinson 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 565 KB